Facilitated By

San Antonio Medical Foundation

News

  • Novartis to Acquire Excellergy in $2 Billion Deal - San Francisco Today

    San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ... A San Francisco-based biotech firm that is being acquired by Novartis.

  • SignaBlok Receives Orphan Drug Designation from FDA for TREM-1 inhibitor for ... - Bergen Record

    SHREWSBURY, MA, UNITED STATES, March 26, 2026 /EINPresswire.com/ — SignaBlok, Inc., a preclinical stage biotechnology ... San Antonio Businesses Traffic ...

  • Comparing Predictive Oncology and Check-Cap Biotech Firms - Eagan Today

    San Antonio · San Diego · San Francisco · San Jose · Seattle · Tampa · Tucson ... Comparing Predictive Oncology and Check-Cap Biotech Firms. Two small- ...

  • Satellos Bioscience: Q4 Earnings Snapshot | kens5.com

    Satellos Bioscience Inc. (MSLE) on Friday reported a loss of $7.3 ... Download the San Antonio News from KENS 5 App. Download on the App Store ...

  • Wolfe Research Initiates Coverage on Krystal Biotech - Today in Pittsburgh

    ... biotechnology company is focused on developing gene therapies for rare dermatological diseases ... San Antonio · San Diego · San Francisco · San Jose ...